Augmentation of Tissue Transglutaminase Expression and Activation by Epidermal Growth Factor Inhibit Doxorubicin-induced Apoptosis in Human Breast Cancer Cells
Open Access
- 1 October 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (40) , 41461-41467
- https://doi.org/10.1074/jbc.m404976200
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cell Type-specific Activation of Intracellular Transglutaminase 2 by Oxidative Stress or Ultraviolet IrradiationPublished by Elsevier ,2004
- Tissue Transglutaminase Mediates Activation of RhoA and MAP Kinase Pathways during Retinoic Acid-induced Neuronal Differentiation of SH-SY5Y CellsJournal of Biological Chemistry, 2003
- Activation of the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway by Retinoic Acid Is Required for Neural Differentiation of SH-SY5Y Human Neuroblastoma CellsJournal of Biological Chemistry, 2002
- GTP is required to stabilize and display transamidation activity of transglutaminase 2Biochemical and Biophysical Research Communications, 2002
- Targeted Inactivation of Gh/Tissue Transglutaminase IIJournal of Biological Chemistry, 2001
- Increased endothelial expression of transglutaminase in glioblastomasNeuropathology and Applied Neurobiology, 1997
- Biochemical Effects of Retinoic Acid on GTP-binding Protein/Transglutaminases in HeLa CellsJournal of Biological Chemistry, 1996
- Identification and biochemical characterization of an 80 kilodalton GTP-binding/transglutaminase from rabbit liver nucleiBiochemistry, 1995
- High levels of transglutaminase expression in doxorubicin‐resistant human breast carcinoma cellsInternational Journal of Cancer, 1994
- TransglutaminasesAnnual Review of Biochemistry, 1980